ROLE OF METABOLIC THERAPY IN TREATMENT OF MYOCARDIUM DYSTROPHY IN CHILDREN
<em>The objective of present research was studying of influence of co-enzyme Q10 (Kudesan) on cardiovascular system in children with myocardial dystrophy (MCD). Patients were divided on two comparable groups (n = 20 and n = 28) according to clinical symptoms of MCD, changes on electrocardiogra...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2010-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <em>The objective of present research was studying of influence of co-enzyme Q10 (Kudesan) on cardiovascular system in children with myocardial dystrophy (MCD). Patients were divided on two comparable groups (n = 20 and n = 28) according to clinical symptoms of MCD, changes on electrocardiogram (ECG) and results of echocardiography. Patients received non-drug means (massage, physical training in treatment regimen, psycho- and reflexotherapy) and vasoactive, nootropic and sedative medications; patients from 2<sup>n</sup><sup>d</sup> group were additionally treated with co-enzyme Q10 during 4 weeks. It was shown that inclusion of co-enzyme Q10 in complex treatment of MCD resulted in beneficial effect on self-feeling of child, favored to disappearance of repolarization disorders on ECG and increase of ejectional fraction. Thus, using of co-enzyme Q10 in complex treatment of children with MCD is reasonable.</em> <br /><strong><em>Key words: children, myocardial dystrophy, co-enzyme Q10, treatment.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii - </em></em></em>Current Pediatrics. 2010;9(5):18-23)</em></span> |
|---|---|
| Item Description: | 1682-5527 1682-5535 |